258 related articles for article (PubMed ID: 30776291)
1. Quality of Life in Hypoparathyroidism Improves With rhPTH(1-84) Throughout 8 Years of Therapy.
Tabacco G; Tay YD; Cusano NE; Williams J; Omeragic B; Majeed R; Almonte MG; Rubin MR; Bilezikian JP
J Clin Endocrinol Metab; 2019 Jul; 104(7):2748-2756. PubMed ID: 30776291
[TBL] [Abstract][Full Text] [Related]
2. PTH(1-34) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Palermo A; Santonati A; Tabacco G; Bosco D; Spada A; Pedone C; Raggiunti B; Doris T; Maggi D; Grimaldi F; Manfrini S; Vescini F
J Clin Endocrinol Metab; 2018 Jan; 103(1):271-280. PubMed ID: 29099939
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism.
Vokes TJ; Mannstadt M; Levine MA; Clarke BL; Lakatos P; Chen K; Piccolo R; Krasner A; Shoback DM; Bilezikian JP
J Clin Endocrinol Metab; 2018 Feb; 103(2):722-731. PubMed ID: 29099947
[TBL] [Abstract][Full Text] [Related]
4. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
Rubin MR; Cusano NE; Fan WW; Delgado Y; Zhang C; Costa AG; Cremers S; Dworakowski E; Bilezikian JP
J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931
[TBL] [Abstract][Full Text] [Related]
5. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
[TBL] [Abstract][Full Text] [Related]
6. PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy.
Cusano NE; Rubin MR; McMahon DJ; Irani D; Anderson L; Levy E; Bilezikian JP
J Clin Endocrinol Metab; 2014 Oct; 99(10):3694-9. PubMed ID: 24978675
[TBL] [Abstract][Full Text] [Related]
7. [Hypoparathyroidism treated with recombinant human parathyroid hormone [rhPTH(1-84)]].
Ramacciotti CF; Pereyra MC; Cohen EN
Medicina (B Aires); 2020; 80(3):289-291. PubMed ID: 32442945
[TBL] [Abstract][Full Text] [Related]
8. Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety.
Tay YD; Tabacco G; Cusano NE; Williams J; Omeragic B; Majeed R; Gomez Almonte M; Bilezikian JP; Rubin MR
J Clin Endocrinol Metab; 2019 Nov; 104(11):5601-5610. PubMed ID: 31310310
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
10. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.
Clarke BL; Vokes TJ; Bilezikian JP; Shoback DM; Lagast H; Mannstadt M
Endocrine; 2017 Jan; 55(1):273-282. PubMed ID: 27734257
[TBL] [Abstract][Full Text] [Related]
11. The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics.
Gittoes N; Rejnmark L; Ing SW; Brandi ML; Björnsdottir S; Hahner S; Hofbauer LC; Houillier P; Khan AA; Levine MA; Mannstadt M; Shoback DM; Vokes TJ; Zhang P; Marelli C; Germak J; Clarke BL
BMC Endocr Disord; 2021 Nov; 21(1):232. PubMed ID: 34801015
[TBL] [Abstract][Full Text] [Related]
12. The effect of PTH(1-84) on quality of life in hypoparathyroidism.
Cusano NE; Rubin MR; McMahon DJ; Irani D; Tulley A; Sliney J; Bilezikian JP
J Clin Endocrinol Metab; 2013 Jun; 98(6):2356-61. PubMed ID: 23596139
[TBL] [Abstract][Full Text] [Related]
13. AN OPEN-LABEL EXTENSION STUDY OF PARATHYROID HORMONE RHPTH(1-84) IN ADULTS WITH HYPOPARATHYROIDISM.
Lakatos P; Bajnok L; Lagast H; Valkusz Z
Endocr Pract; 2016 May; 22(5):523-32. PubMed ID: 26684150
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.
Mannstadt M; Clarke BL; Bilezikian JP; Bone H; Denham D; Levine MA; Peacock M; Rothman J; Shoback DM; Warren ML; Watts NB; Lee HM; Sherry N; Vokes TJ
J Clin Endocrinol Metab; 2019 Nov; 104(11):5136-5147. PubMed ID: 31369089
[TBL] [Abstract][Full Text] [Related]
15. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.
Sikjaer T; Amstrup AK; Rolighed L; Kjaer SG; Mosekilde L; Rejnmark L
J Bone Miner Res; 2013 Oct; 28(10):2232-43. PubMed ID: 23649554
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.
Winer KK; Sinaii N; Reynolds J; Peterson D; Dowdy K; Cutler GB
J Clin Endocrinol Metab; 2010 Jun; 95(6):2680-8. PubMed ID: 20392870
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study.
Mannstadt M; Clarke BL; Vokes T; Brandi ML; Ranganath L; Fraser WD; Lakatos P; Bajnok L; Garceau R; Mosekilde L; Lagast H; Shoback D; Bilezikian JP
Lancet Diabetes Endocrinol; 2013 Dec; 1(4):275-83. PubMed ID: 24622413
[TBL] [Abstract][Full Text] [Related]
18. Alfacalcidol vs Calcitriol in the Management of Patient With Hypoparathyroidism: A Randomized Controlled Trial.
Saha S; Sreenivas V; Goswami R
J Clin Endocrinol Metab; 2021 Jun; 106(7):2092-2102. PubMed ID: 33616655
[TBL] [Abstract][Full Text] [Related]
19. Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1-84).
Chen KS; Gosmanova EO; Curhan GC; Ketteler M; Rubin M; Swallow E; Zhao J; Wang J; Sherry N; Krasner A; Bilezikian JP
J Clin Endocrinol Metab; 2020 Oct; 105(10):e3557-65. PubMed ID: 32738041
[TBL] [Abstract][Full Text] [Related]
20. Extended Treatment With Recombinant Human Parathyroid Hormone (1-84) in Adult Patients With Chronic Hypoparathyroidism.
Rubin MR; Cusano N; Yin S; Tokareva E; Ayodele O; Finkelman RD
Endocr Pract; 2024 Mar; 30(3):200-208. PubMed ID: 38086524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
